1-9 of 9
Junhua Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Response Rates across Lines of Therapy Among Patients with Relapsed/Refractory Follicular Lymphoma

Tycel Philips, Laurie H. Sehn, Anthony Wang, Junhua Yu, Elizabeth H. Marchlewicz, Rajesh Kamalakar, Kavita Sail, Donald Arnette, Shibing Yang, Alex Mutebi, Fernando Rivas Navarro, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 1683.
https://doi.org/10.1182/blood-2023-180088
Published: 2023
Journal Articles

Real-World Evaluation of Outcomes in Relapsed/Refractory Multiple Myeloma Patients That Are Triple-Class Exposed after Receiving 2 or More Prior Lines of Therapy

Katherine Radwanski, Junhua Yu, Kody Pierce, Chetasi Talati, Steve Stricker, Shiyin Jiao, Orlando Bueno
Journal: Blood
Blood (2023) 142 (Supplement 1): 3358.
https://doi.org/10.1182/blood-2023-178824
Published: 2023
Journal Articles

Real-World Progression-Free Survival and Treatment Patterns for t(11;14) Positive Patients with Multiple Myeloma with at Least 2 Prior Lines of Treatment

Allicia Girvan, Daniel Martins, Junhua Yu, Sophia Ng, Rajesh Kamalakar, Faiza Zafar, Seema Tulsian, Robert F. Cornell, Mohamed Samir
Journal: Blood
Blood (2023) 142 (Supplement 1): 6667.
https://doi.org/10.1182/blood-2023-173446
Published: 2023
Journal Articles

Patterns of Care and Resource Use Among Elderly Relapsed/Refractory Follicular Lymphoma Patients: US Medicare Claims Analysis

Savreet Bains Chawla, Shibing Yang, Jing He, Monika Jun, Nicole Heaps, Anthony Wang, Junhua Yu, Chenxue Liang, Allison Keshishian, Jon Ukropec
Journal: Blood
Blood (2023) 142 (Supplement 1): 5158.
https://doi.org/10.1182/blood-2023-181854
Published: 2023
Journal Articles

Estimation of Relapsed/Refractory Follicular Lymphoma Patients on Therapy in the United States

Karissa Johnston, Mark Bennett, Savreet Bains Chawla, Shibing Yang, Anthony Wang, Junhua Yu, Monika Jun
Journal: Blood
Blood (2023) 142 (Supplement 1): 6148.
https://doi.org/10.1182/blood-2023-182030
Published: 2023
Journal Articles

Follicular Lymphoma Treatment Patterns and Outcomes over Time: A Real-World Analysis in the United States

Tycel Phillips, Junhua Yu, Rajesh Kamalakar, Kalatu R. Davies, Alex Mutebi, Savreet Bains Chawla, Donald Arnette, Syed Quadri, Anthony Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 5241–5243.
https://doi.org/10.1182/blood-2022-157773
Published: 2022
Journal Articles

Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Receiving ≥3 Lines of Therapy: A Real-World Evaluation in the United States

Allicia Girvan, Junhua Yu, Rajesh Kamalakar, Elizabeth S. Mearns, Michael Nixon, Robert F. Cornell
Journal: Blood
Blood (2022) 140 (Supplement 1): 5288–5290.
https://doi.org/10.1182/blood-2022-156225
Published: 2022
Journal Articles

Real-World Treatment Patterns and Outcomes of Daratumumab Retreatment in Multiple Myeloma in the United States

Allicia Girvan, Junhua Yu, Nnadozie Emechebe, Rajesh Kamalakar, Yan Luo
Journal: Blood
Blood (2022) 140 (Supplement 1): 5266–5267.
https://doi.org/10.1182/blood-2022-158270
Published: 2022
Journal Articles

Health Care Resource Utilization and Costs of CAR T Therapy in Patients with Large B-Cell Lymphoma: A Retrospective US Claims Database Analysis

Kalatu R. Davies, Rajesh Kamalakar, Junhua Yu, Yinan Huang, Anthony Wang, Kavita Sail, Thomas Doerr, Simon Sharmokh, Alex Mutebi, Gilles Salles
Journal: Blood
Blood (2022) 140 (Supplement 1): 5058–5059.
https://doi.org/10.1182/blood-2022-157758
Published: 2022